Reuters logo
BRIEF-Bioinvent CEO to step down amid increased focus on clinical development
October 24, 2017 / 1:43 PM / 25 days ago

BRIEF-Bioinvent CEO to step down amid increased focus on clinical development

Oct 24 (Reuters) - Bioinvent International Ab

* ceo michael oredsson will resign at the end of the year

* board has initiated a process to recruit a new CEO

* says both the board and Michael believe that it is a good time for a change in leadership, as the company is transitioning to a specific focus on clinical development and R&D

* says company now needs more scientific skills in CEO role

* If a new CEO is not in place by 1 January, 2018, the present CSO, Björn Frendéus, will serve as acting CEO until the new CEO has been appointed and taken office Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below